INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 223 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $381,000 | +162.8% | 41,100 | +151.3% | 0.09% | +131.6% |
| Q4 2020 | $145,000 | -92.7% | 16,354 | -90.4% | 0.04% | -92.2% |
| Q3 2020 | $1,986,000 | +425.4% | 171,200 | +237.0% | 0.48% | +491.5% |
| Q1 2020 | $378,000 | +285.7% | 50,799 | +379.2% | 0.08% | +39.0% |
| Q2 2016 | $98,000 | – | 10,600 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
| STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
| Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
| WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
| Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
| Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
| EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
| Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
| Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |